Although the incidences of TMB-H and MSI-H are low in HCC, other genomic features, such as CTNNB1 mutations, angiogenesis signatures, and inflammatory gene expression profiles, may hold greater predictive potential and are under active investigation. Here, CTNNB1 is linked to hepatocellular carcinoma.